Read the story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Last hour:
Last 24 hours:

Starton Therapeutics says target to start Phase 1 study for STAR-LLD for chronic lymphocytic leukemia remains on track for 4Q

% of readers think this story is Fact. Add your two cents.

Starton Therapeutics Inc, a privately-held clinical-stage biopharmaceutical company, said its target of kicking off a Phase 1 clinical study of STAR-LLD for treating chronic lymphocytic leukemia (CLL) in the fourth quarter of 2021 remains on track. 

It comes after the company said it had now completed a written Type B pre-Investigational New Drug (pre-IND) meeting with the regulator, the US Food and Drug Administration (FDA). 

READ: Starton Therapeutics secures licensing deal to develop post-cancer treatment nausea therapy STAR-OLZ in China

Based on the FDA’s feedback from the written response meeting, Starton will conduct a Phase 1 relative bioavailability (BA) study of STAR-LLD, a subcutaneously administered lenalidomide solution, compared to oral administration of REVLIMID in multiple myeloma patients currently receiving REVLIMID.

Based on the outcome of this Phase 1 study, the FDA has also confirmed a 505(b)(2) regulatory pathway is acceptable, allowing the potential to accelerate the clinical development for drug approval, noted Starton.

In today’s statement, Starton also said it expects to complete the non-clinical requirements for the IND submission in the third quarter of this year.

“We are very pleased with the outcome of the pre-IND meeting and will move forward with our plans to initiate clinical studies before the end of 2021,” said Pedro Lichtinger, Starton’s chief executive.

“We appreciate the FDA’s guidance as we work towards developing the first immunomodulatory (IMiD) drug approved for CLL.”

Starton is focused on transforming standard-of-care therapeutics, using proven continuous delivery technology. It develops transdermal and subcutaneous delivery treatments that administer continuously medicines via patches placed on the skin or ambulatory pumps under the skin, respectively.

STAR-LLD SC is a continuous subcutaneous infusion of lenalidomide parenteral solution via an infusion pump. Starton is also developing a once-weekly transdermal delivery patch system.

STAR-LLD SC will use an ambulatory pump to infuse low-dose lenalidomide continuously, based on Starton research showing that low-dose continuous delivery may improve overall response rates and progression-free survival alone or in combination with standard therapies. STAR-LLD is expected to be the first Immunomodulatory imide (IMiD) drug available for CLL.

Contact the author at [email protected]

Story by ProactiveInvestors


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!

Order by Phone at 888-809-8385 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse


    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    Load more ...




    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.